Кипролис
(Карфилзомиб)
(60 mg)
(one)
(Фл)
Kyprolis (Carfilzomib*) 60 мг, AMGEN
Top Sales
In Stock
Indications for use
As part of combination therapy for relapsed multiple myeloma in patients who have received at least 1 line of previous therapy, in combination with lenalidomide and dexamethasone.
Monotherapy for relapsed and refractory multiple myeloma in patients who have received at least 2 previous lines of therapy, including bortezomib and an immunomodulatory agent.
-
Commercial name:Кипролис
-
Сhemical name:Карфилзомиб
-
Dosage:60 mg
-
Quantity:one
-
Release form:Фл
-
Производитель:Amgen
No reviews yet